Gastrointestinal and liver disease in Adult Life After Childhood Cancer in Scandinavia: A population‐based cohort study
Open Access
- 19 May 2016
- journal article
- cancer epidemiology
- Published by Wiley in International Journal of Cancer
- Vol. 139 (7) , 1501-1511
Abstract
Survival after childhood cancer diagnosis has remarkably improved, but emerging evidence suggests that cancer‐directed therapy may have adverse gastrointestinal late effects. We aimed to comprehensively assess the frequency of gastrointestinal and liver late effects among childhood cancer survivors and compare this frequency with the general population. Our population‐based cohort study included all 1‐year survivors of childhood and adolescent cancer in Denmark, Finland, Iceland, Norway and Sweden diagnosed from the 1940s and 1950s. Our outcomes of interest were hospitalization rates for gastrointestinal and liver diseases, which were ascertained from national patient registries. We calculated standardized hospitalization rate ratios (RRs) and absolute excess rates comparing hospitalizations of any gastrointestinal or liver disease and for specific disease entities between survivors and the general population. The study included 31,132 survivors and 207,041 comparison subjects. The median follow‐up in the hospital registries were 10 years (range: 0–42) with 23% of the survivors being followed at least to the age of 40 years. Overall, survivors had a 60% relative excess of gastrointestinal or liver diseases [RR: 1.6, 95% confidence interval (CI): 1.6–1.7], which corresponds to an absolute excess of 360 (95% CI: 330–390) hospitalizations per 100,000 person‐years. Survivors of hepatic tumors, neuroblastoma and leukemia had the highest excess of gastrointestinal and liver diseases. In addition, we observed a relative excess of several specific diseases such as esophageal stricture (RR: 13; 95% CI: 9.2–20) and liver cirrhosis (RR: 2.9; 95% CI: 2.0–4.1). Our findings provide useful information about the breadth and magnitude of late complications among childhood cancer survivors and can be used for generating hypotheses about potential exposures related to these gastrointestinal and liver late effects.Keywords
Funding Information
- Danish Council for Strategic Research (09-066899)
- Danish Child Cancer Foundation
This publication has 46 references indexed in Scilit:
- The Adult Life After Childhood Cancer in Scandinavia (ALiCCS) Study: Design and CharacteristicsPediatric Blood & Cancer, 2015
- Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based studyThe Lancet Oncology, 2014
- Data quality at the Icelandic Cancer Registry: Comparability, validity, timeliness and completenessActa Oncologica, 2012
- The Danish Cancer RegistryScandinavian Journal of Public Health, 2011
- Survivors of Childhood Cancer Have Increased Risk of Gastrointestinal Complications Later in LifeGastroenterology, 2011
- Lifelong Cancer Incidence in 47 697 Patients Treated for Childhood Cancer in the Nordic CountriesJNCI: Journal of the National Cancer Institute, 2009
- The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention ResearchJournal of Clinical Oncology, 2009
- Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timelinessEuropean Journal of Cancer, 2009
- Acute and long-term gastrointestinal consequences of chemotherapyBest Practice & Research Clinical Gastroenterology, 2009
- Health‐status of adult survivors of childhood cancer: A large‐scale population‐based study from the British childhood cancer survivor studyInternational Journal of Cancer, 2007